Tekla Capital Management as of Sept. 30, 2015
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 135 positions in its portfolio as reported in the September 2015 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 7.8 | $218M | 2.2M | 98.19 | |
| Celgene Corporation | 7.0 | $196M | 1.8M | 108.17 | |
| Biogen Idec (BIIB) | 4.9 | $136M | 467k | 291.81 | |
| Incyte Corporation (INCY) | 3.9 | $108M | 974k | 110.33 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.8 | $105M | 1.0M | 104.14 | |
| Alexion Pharmaceuticals | 3.7 | $102M | 655k | 156.39 | |
| Allergan | 3.5 | $96M | 353k | 271.81 | |
| Johnson & Johnson (JNJ) | 3.2 | $88M | 941k | 93.35 | |
| Mylan Nv | 3.1 | $87M | 2.2M | 40.26 | |
| Teva Pharmaceutical Industries (TEVA) | 2.8 | $78M | 1.4M | 56.46 | |
| Alkermes (ALKS) | 2.8 | $78M | 1.3M | 58.67 | |
| Regeneron Pharmaceuticals (REGN) | 2.6 | $72M | 154k | 465.14 | |
| BioMarin Pharmaceutical (BMRN) | 2.3 | $64M | 606k | 105.32 | |
| Pfizer (PFE) | 2.0 | $57M | 1.8M | 31.41 | |
| Illumina (ILMN) | 1.9 | $53M | 301k | 175.82 | |
| UnitedHealth (UNH) | 1.7 | $47M | 402k | 116.01 | |
| Aetna | 1.6 | $46M | 416k | 109.41 | |
| Amgen (AMGN) | 1.6 | $45M | 322k | 138.32 | |
| Bristol Myers Squibb (BMY) | 1.5 | $42M | 712k | 59.20 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 1.3 | $37M | 13M | 2.83 | |
| Merck & Co (MRK) | 1.2 | $34M | 681k | 49.39 | |
| Humana (HUM) | 1.2 | $34M | 188k | 179.00 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $25M | 311k | 80.36 | |
| Akorn | 0.9 | $24M | 850k | 28.50 | |
| Molina Healthcare (MOH) | 0.9 | $24M | 348k | 68.85 | |
| United Therapeutics Corporation (UTHR) | 0.9 | $24M | 183k | 131.24 | |
| Medicines Company | 0.8 | $24M | 624k | 37.96 | |
| Endo International | 0.8 | $22M | 320k | 69.28 | |
| Allscripts Healthcare Solutions (MDRX) | 0.8 | $22M | 1.8M | 12.40 | |
| Agilent Technologies Inc C ommon (A) | 0.8 | $22M | 636k | 34.33 | |
| Ventas (VTR) | 0.7 | $21M | 369k | 56.06 | |
| CIGNA Corporation | 0.7 | $20M | 149k | 135.02 | |
| Medtronic (MDT) | 0.7 | $19M | 290k | 66.94 | |
| Hca Holdings (HCA) | 0.7 | $19M | 243k | 77.36 | |
| ACADIA Pharmaceuticals (ACAD) | 0.7 | $19M | 563k | 33.07 | |
| Physicians Realty Trust | 0.7 | $19M | 1.2M | 15.09 | |
| Medical Properties Trust (MPW) | 0.7 | $18M | 1.6M | 11.06 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.6 | $18M | 58k | 303.33 | |
| Novo Nordisk A/S (NVO) | 0.6 | $16M | 295k | 54.24 | |
| Anacor Pharmaceuticals In | 0.6 | $15M | 131k | 117.71 | |
| Neurocrine Biosciences (NBIX) | 0.5 | $15M | 376k | 39.79 | |
| Alere | 0.5 | $14M | 298k | 48.15 | |
| Omega Healthcare Investors (OHI) | 0.5 | $15M | 413k | 35.15 | |
| Paratek Pharmaceuticals | 0.5 | $15M | 763k | 19.00 | |
| Bluebird Bio (BLUE) | 0.5 | $14M | 161k | 85.55 | |
| Corsicanto Ltd conv bnd | 0.5 | $14M | 15M | 0.92 | |
| Karyopharm Therapeutics (KPTI) | 0.5 | $13M | 1.2M | 10.53 | |
| McKesson Corporation (MCK) | 0.5 | $13M | 68k | 185.04 | |
| Impax Laboratories | 0.4 | $12M | 345k | 35.21 | |
| Gw Pharmaceuticals Plc ads | 0.4 | $12M | 135k | 91.37 | |
| Welltower Inc 6.50% pfd prepet | 0.4 | $12M | 200k | 60.73 | |
| Stryker Corporation (SYK) | 0.4 | $12M | 124k | 94.10 | |
| Ardelyx (ARDX) | 0.4 | $11M | 640k | 17.28 | |
| GlaxoSmithKline | 0.4 | $11M | 285k | 38.45 | |
| Senior Housing Properties Trust | 0.4 | $11M | 671k | 16.20 | |
| Baxter International (BAX) | 0.4 | $11M | 320k | 32.85 | |
| Thermo Fisher Scientific (TMO) | 0.4 | $11M | 86k | 122.28 | |
| Sabra Health Care REIT (SBRA) | 0.4 | $11M | 456k | 23.18 | |
| Puma Biotechnology (PBYI) | 0.4 | $11M | 141k | 75.36 | |
| Shire | 0.4 | $10M | 50k | 205.24 | |
| St. Jude Medical | 0.4 | $10M | 162k | 63.09 | |
| LTC Properties (LTC) | 0.4 | $10M | 237k | 42.67 | |
| Baxalta Incorporated | 0.4 | $10M | 320k | 31.51 | |
| IDEXX Laboratories (IDXX) | 0.3 | $9.8M | 132k | 74.25 | |
| Zimmer Holdings (ZBH) | 0.3 | $9.6M | 102k | 93.93 | |
| Community Health Systems (CYH) | 0.3 | $9.0M | 210k | 42.77 | |
| Abbvie (ABBV) | 0.3 | $8.9M | 164k | 54.41 | |
| Natera (NTRA) | 0.3 | $8.8M | 814k | 10.85 | |
| Novartis (NVS) | 0.3 | $8.5M | 93k | 91.92 | |
| Medivation | 0.3 | $8.7M | 205k | 42.50 | |
| Ultragenyx Pharmaceutical (RARE) | 0.3 | $8.5M | 88k | 96.31 | |
| WellCare Health Plans | 0.3 | $7.6M | 89k | 86.18 | |
| Sage Therapeutics (SAGE) | 0.3 | $7.6M | 181k | 42.32 | |
| Auris Med Hldg | 0.3 | $7.5M | 2.1M | 3.56 | |
| Juno Therapeutics | 0.3 | $7.4M | 182k | 40.69 | |
| Lexicon Pharmaceuticals (LXRX) | 0.3 | $7.6M | 708k | 10.74 | |
| Eli Lilly & Co. (LLY) | 0.3 | $7.2M | 86k | 83.68 | |
| Merrimack Pharmaceuticals In | 0.3 | $7.3M | 854k | 8.51 | |
| Pieris Pharmaceuticals | 0.2 | $7.0M | 3.8M | 1.83 | |
| Endologix | 0.2 | $6.8M | 551k | 12.26 | |
| Dynavax Technologies (DVAX) | 0.2 | $6.7M | 275k | 24.54 | |
| Centene Corporation (CNC) | 0.2 | $6.5M | 120k | 54.23 | |
| Sagent Pharmaceuticals | 0.2 | $6.3M | 410k | 15.33 | |
| Horizon Pharma | 0.2 | $6.5M | 326k | 19.82 | |
| Tenet Healthcare Corporation (THC) | 0.2 | $6.1M | 165k | 36.92 | |
| Intra Cellular Therapies (ITCI) | 0.2 | $6.0M | 150k | 40.04 | |
| ISIS Pharmaceuticals | 0.2 | $5.9M | 147k | 40.42 | |
| Supernus Pharmaceuticals note 7.500 5/0 | 0.2 | $5.5M | 2.0M | 2.77 | |
| Alliqua | 0.2 | $5.2M | 1.7M | 3.17 | |
| Heron Therapeutics (HRTX) | 0.2 | $5.3M | 219k | 24.40 | |
| Icon (ICLR) | 0.2 | $5.1M | 72k | 70.97 | |
| Healthcare Realty Trust Incorporated | 0.2 | $4.7M | 187k | 24.85 | |
| Mallinckrodt Pub | 0.2 | $4.7M | 73k | 63.94 | |
| Esperion Therapeutics (ESPR) | 0.2 | $4.9M | 206k | 23.59 | |
| Allergan Plc pfd conv ser a | 0.2 | $4.7M | 5.0k | 943.40 | |
| Foamix Pharmaceuticals | 0.2 | $4.5M | 614k | 7.33 | |
| Spectrum Pharmaceuticals Inc conv | 0.2 | $4.5M | 5.0M | 0.89 | |
| Uniqure Nv (QURE) | 0.1 | $4.2M | 206k | 20.45 | |
| Cellectis S A (CLLS) | 0.1 | $4.2M | 158k | 26.36 | |
| Arca Biopharma | 0.1 | $4.0M | 811k | 4.97 | |
| DepoMed | 0.1 | $3.8M | 200k | 18.85 | |
| Achillion Pharmaceuticals | 0.1 | $3.8M | 547k | 6.91 | |
| Inotek Pharmaceuticals | 0.1 | $4.0M | 425k | 9.40 | |
| Celldex Therapeutics | 0.1 | $3.6M | 338k | 10.54 | |
| Wright Medical | 0.1 | $3.3M | 156k | 21.02 | |
| Epizyme | 0.1 | $3.3M | 257k | 12.86 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $3.4M | 282k | 11.97 | |
| Trovagene | 0.1 | $3.1M | 550k | 5.69 | |
| Perrigo Company (PRGO) | 0.1 | $3.0M | 19k | 157.25 | |
| Forward Pharma A/s | 0.1 | $3.1M | 132k | 23.56 | |
| Aegerion Pharmaceuticals | 0.1 | $2.8M | 206k | 13.60 | |
| Flex Pharma | 0.1 | $2.8M | 233k | 12.01 | |
| Care Cap Properties | 0.1 | $2.8M | 84k | 32.94 | |
| Momenta Pharmaceuticals | 0.1 | $2.5M | 154k | 16.41 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.1 | $2.5M | 83k | 30.40 | |
| Accelr8 Technology | 0.1 | $2.3M | 145k | 16.18 | |
| Merrimack Pharmaceuticals In note 4.500% 7/1 | 0.1 | $2.3M | 1.5M | 1.57 | |
| Dbv Technologies S A | 0.1 | $2.3M | 66k | 35.59 | |
| Tetralogic Pharmaceuticals c note 8.000% 6/1 | 0.1 | $2.3M | 4.5M | 0.52 | |
| Chimerix (CMRX) | 0.1 | $1.8M | 48k | 38.20 | |
| GenMark Diagnostics | 0.1 | $1.7M | 215k | 7.87 | |
| BioDelivery Sciences International | 0.1 | $1.4M | 250k | 5.56 | |
| Tetraphase Pharmaceuticals | 0.1 | $1.4M | 192k | 7.46 | |
| Affimed Therapeutics B V | 0.1 | $1.4M | 228k | 6.17 | |
| Abaxis | 0.0 | $988k | 23k | 43.98 | |
| Verastem | 0.0 | $895k | 500k | 1.79 | |
| Bellicum Pharma | 0.0 | $872k | 60k | 14.53 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $847k | 65k | 13.03 | |
| Galapagos Nv- (GLPG) | 0.0 | $814k | 20k | 40.70 | |
| Cynapsus Therapeutics | 0.0 | $799k | 49k | 16.20 | |
| Zafgen | 0.0 | $425k | 13k | 31.94 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $636k | 50k | 12.72 | |
| Macrogenics (MGNX) | 0.0 | $273k | 13k | 21.42 | |
| Xencor (XNCR) | 0.0 | $245k | 20k | 12.25 | |
| Kite Pharma | 0.0 | $351k | 6.3k | 55.71 |
